5:54 PM
 | 
Sep 10, 2013
 |  BC Extra  |  Politics & Policy

FDA announces classwide changes for opioids

FDA on Tuesday announced classwide labeling changes and new postmarket study...

Read the full 32 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >